Psoriatic inflammation facilitates the onset of arthritis in a mouse model

Journal of Investigative Dermatology

Volumn 135, Issue 2, 2015, Pages 445-453

  Yamamoto, Mayuko ^a   Nakajima, Kimiko ^a   Takaishi, Mikiro ^a   Kitaba, Shun ^b   Magata, Yasuhiro ^c   Kataoka, Sayo ^a   Sano, Shigetoshi ^a  

^a KOCHI UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PHORBOL 13 ACETATE 12 MYRISTATE; STAT3 PROTEIN; CYTOKINE; STAT3 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE EROSION; CELL INFILTRATION; CONTROLLED STUDY; DISEASE EXACERBATION; ENTHESITIS; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; KERATINOCYTE; MONONUCLEAR CELL; MOUSE; MOUSE MODEL; NONHUMAN; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH17 CELL; TRANSGENIC MOUSE; ANIMAL; ARTHRITIS, PSORIATIC; ARTHROPATHY; C57BL MOUSE; COMPLICATION; DISEASE MODEL; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; PSORIASIS; SKIN DISEASE;

ANIMALS; ARTHRITIS, PSORIATIC; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION; JOINT DISEASES; MICE; MICE, INBRED C57BL; PSORIASIS; SKIN DISEASES; STAT3 TRANSCRIPTION FACTOR; TETRADECANOYLPHORBOL ACETATE; TH17 CELLS;

EID: 84922401338     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2014.426     Document Type: Article

References (45)

1. Atsumi T, Ishihara K, Kamimura D et al. (2002) A point mutation of Tyr-759 in interleukin 6 family cytokine receptor subunit gp130 causes autoimmune arthritis. J Exp Med 196:979-90.
2. Boehncke WH, Kirby B, Fitzgerald O et al. (2014) New developments in our understanding of psoriatic arthritis and their impact on the diagnosis and clinical management of the disease. J Eur Acad Dermatol Venereol 28:264-70.
3. Bonifati C, Trento E, Cordiali-Fei P et al. (1997) Increased interleukin-7 concentrations in lesional skin and in the sera of patients with plaquetype psoriasis. Clin Immunol Immunopathol 83:41-4.
4. Cenit MC, Ortego-Centeno N, Raya E et al. (2013) Influence of the STAT3 genetic variants in the susceptibility to psoriatic arthritis and Behcet's disease. Hum Immunol 74:230-3.
5. Colucci S, Brunetti G, Cantatore FP et al. (2007) Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol 212:47-55.
6. Danoy P, Pryce K, Hadler J et al. (2010) Association of variants at 1q32 and STAT3 with ankylosing spondylitis suggests genetic overlap with Crohn's disease. PLoS Genet 6:e1001195.
7. Elder JT, Bruce AT, Gudjonsson JE et al. (2010) Molecular dissection of psoriasis: integrating genetics and biology. J Invest Dermatol 130:1213-26.
8. Fitch E, Harper E, Skorcheva I et al. (2007) Pathophysiology of psoriasis: recent advances on IL-23 and Th17 cytokines. Curr Rheumatol Rep 9:461-7.
9. Gladman DD, Antoni C, Mease P et al. (2005) Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis 64(Suppl 2): ii14-7.
10. Gottlieb A, Korman NJ, Gordon KB et al. (2008) Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 58:851-64.
11. Harper EG, Guo C, Rizzo H et al. (2009) Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis. J Invest Dermatol 129:2175-83.
12. Hedrick MN, Lonsdorf AS, Shirakawa AK et al. (2009) CCR6 is required for IL-23-induced psoriasis-like inflammation in mice. J Clin Invest 119:2317-29.
13. Hwang J, Kita R, Kwon HS et al. (2011) Epidermal ablation of Dlx3 is linked to IL-17-associated skin inflammation. Proc Natl Acad Sci USA 108: 11566-71.
14. Jandus C, Bioley G, Rivals JP et al. (2008) Increased numbers of circulating polyfunctional Th17 memory cells in patients with seronegative spondylarthritides. Arthritis Rheum 58:2307-17.
15. Krueger GG, Langley RG, Leonardi C et al. (2007) A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med 356:580-92.
16. Leipe J, Grunke M, Dechant C et al. (2010) Role of Th17 cells in human autoimmune arthritis. Arthritis Rheum 62:2876-85.
17. Lloyd P, Ryan C, Menter A (2012) Psoriatic arthritis: An update. Arthritis 2012:176298.
18. Lories RJ, de Vlam K (2012) Is psoriatic arthritis a result of abnormalities in acquired or innate immunity? Curr Rheumatol Rep 14:375-82.
19. Lubberts E (2010) Th17 cytokines and arthritis. Semin Immunopathol 32:43-53.
20. McGonagle D, Ash Z, Dickie L et al. (2011) The early phase of psoriatic arthritis. Ann Rheum Dis 70(Suppl 1):i71-6.
21. McGonagle D, Lories RJ, Tan AL et al. (2007) The concept of a "synovioentheseal complex" and its implications for understanding joint inflammation and damage in psoriatic arthritis and beyond. Arthritis Rheum 56:2482-91.
22. McGonagle D, Tan AL, Benjamin M (2009) The nail as a musculoskeletal appendage-implications for an improved understanding of the link between psoriasis and arthritis. Dermatology 218:97-102.
23. Murakami M, Hirano T (2012) The pathological and physiological roles of IL-6 amplifier activation. Int J Biol Sci 8:1267-80.
24. Murakami M, Okuyama Y, Ogura H et al. (2011) Local microbleeding facilitates IL-6- And IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. J Exp Med 208:103-14.
25. Nakajima K, Kanda T, Takaishi M et al. (2011) Distinct roles of IL-23 and IL-17 in the development of psoriasis-like lesions in a mouse model. J Immunol 186:4481-9.
26. Nograles KE, Brasington RD, Bowcock AM (2009) New insights into the pathogenesis and genetics of psoriatic arthritis. Nat Clin Pract Rheumatol 5:83-91.
27. Nograles KE, Krueger JG (2011) Anti-cytokine therapies for psoriasis. Exp Cell Res 317:1293-300.
28. Ogura H, Murakami M, Okuyama Y et al. (2008) Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29:628-36.
29. Ohtani T, Ishihara K, Atsumi T et al. (2000) Dissection of signaling cascades through gp130 in vivo: reciprocal roles for STAT3- And SHP2-mediated signals in immune responses. Immunity 12:95-105.
30. Punzi L, Pianon M, Bertazzolo N et al. (1998) Clinical, laboratory and immunogenetic aspects of post-traumatic psoriatic arthritis: A study of 25 patients. Clin Exp Rheumatol 16:277-81.
31. Radtke MA, Reich K, Blome C et al. (2009) Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey. J Eur Acad Dermatol Venereol 23:683-91.
32. Rahman P, Elder JT (2012) Genetics of psoriasis and psoriatic arthritis: A report from the GRAPPA 2010 annual meeting. J Rheumatol 39: 431-3.
33. Raychaudhuri SP, Raychaudhuri SK, Genovese MC (2012) IL-17 receptor and its functional significance in psoriatic arthritis. Mol Cell Biochem 359:419-29.
34. Ritchlin C, Haas-Smith SA, Hicks D et al. (1998) Patterns of cytokine production in psoriatic synovium. J Rheumatol 25:1544-52.
35. Sano S, Chan KS, Carbajal S et al. (2005) Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model. Nat Med 11:43-9.
36. Sano S, Chan KS, DiGiovanni J (2008) Impact of Stat3 activation upon skin biology: A dichotomy of its role between homeostasis and diseases. J Dermatol Sci 50:1-14.
37. Sawa S, Kamimura D, Jin GH et al. (2006) Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7- dependent homeostatic proliferation of CD4 T cells. J Exp Med 203:1459-70.
38. Spuls PI, Hooft L (2012) Brodalumab and ixekizumab, anti-interleukin-17- receptor antibodies for psoriasis: A critical appraisal. Br J Dermatol 167:710-3.
39. Takata T, Taniguchi Y, Ohnishi T et al. (2011) 18)FDG PET/CT is a powerful tool for detecting subclinical arthritis in patients with psoriatic arthritis and/or psoriasis vulgaris. J Dermatol Sci 64:144-7.
40. Tan AL, Benjamin M, Toumi H et al. (2007) The relationship between the extensor tendon enthesis and the nail in distal interphalangeal joint disease in psoriatic arthritis-a high-resolution MRI and histological study. Rheumatology (Oxford) 46:253-6.
41. Tan AL, Grainger AJ, Tanner SF et al. (2006) A high-resolution magnetic resonance imaging study of distal interphalangeal joint arthropathy in psoriatic arthritis and osteoarthritis: Are they the same? Arthritis Rheum 54:1328-33.
42. Tan ES, Chong WS, Tey HL (2012) Nail psoriasis: A review. Am J Clin Dermatol 13:375-88.
43. Tsoi LC, Spain SL, Knight J et al. (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44:1341-8.
44. Zaba LC, Cardinale I, Gilleaudeau P et al. (2007) Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med 204:3183-94.
45. Zenz R, Eferl R, Kenner L et al. (2005) Psoriasis-like skin disease and arthritis caused by inducible epidermal deletion of Jun proteins. Nature 437: 369-75.